4/11/2012

Seventh Sense Biosystems is developing its Touch Activated Phlebotomy platform to improve the quality and cost-effectiveness of blood collection for testing. The Cambridge, Mass.-based company has raised $750,000 in a round of debt funding from five backers.

Related Summaries